Nottage W M, McMaster W C
Division of Orthopedics, University of California, Irvine.
Clin Orthop Relat Res. 1990 Feb(251):38-43.
A retrospective study of 76 Bateman universal proximal femoral endoprostheses with a mean follow-up period of 32 months was compared to a group of 36 Thompson endoprostheses and 16 Moore endoprostheses, with a mean follow-up period of 35 months and 31 months, respectively. Harris hip scores, when corrected for preoperatively impaired function, yielded a mean score of 85 for the Bateman group, compared to a mean of 77 for both the Thompson and Moore groups. Fifteen patients received the Bateman device for reconstructive purposes and had a mean Harris hip score of 90. Morbidity was comparable between the Bateman and Thompson groups. The deep-infection rate was 3.9%, and the 32-day perioperative mortality was 4.6%, rising to 29% at the time of review. Preselection factors placed younger, more functional patients in the Bateman group (mean age, 65 years; mortality, 11%), compared to the Thompson group (mean age, 72 years; mortality, 39%) and the Moore group (mean age, 73 years; mortality, 41%). Continued evaluation of the Bateman endoprosthesis is required to better define its potential to lessen the long-term problems of pain, loosening, and acetabular wear.
一项对76例Bateman通用型股骨近端假体的回顾性研究,平均随访期为32个月,将其与一组36例Thompson假体和16例Moore假体进行比较,这两组的平均随访期分别为35个月和31个月。对术前功能受损进行校正后的Harris髋关节评分显示,Bateman组的平均评分为85分,而Thompson组和Moore组的平均评分为77分。15例患者因重建目的接受了Bateman假体,其Harris髋关节平均评分为90分。Bateman组和Thompson组的发病率相当。深部感染率为3.9%,围手术期32天死亡率为4.6%,复查时升至29%。预选择因素使得Bateman组的患者更年轻、功能更好(平均年龄65岁;死亡率11%),相比之下,Thompson组平均年龄72岁,死亡率39%,Moore组平均年龄73岁,死亡率41%。需要对Bateman假体进行持续评估,以更好地确定其减轻疼痛、松动和髋臼磨损等长期问题的潜力。